BERIRAB

This brand name is authorized in Austria, Estonia, Hong Kong, Israel

Active ingredients

The drug BERIRAB contains one active pharmaceutical ingredient (API):

1 Human rabies immunoglobulin UNII 95F619ATQ2 - HUMAN RABIES VIRUS IMMUNE GLOBULIN

Human rabies immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against rabies virus. Human Rabies Immunoglobulin must always be used in combination with a rabies vaccine. Read about Human rabies immunoglobulin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BB05	Rabies immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1887318
Country: HK	Department of Health Drug Office	Identifier(s): 61001, 61002
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9327